Status:
COMPLETED
Smart Watch, Heart Rate and So2 in Cardiac Patients
Lead Sponsor:
Umm Al-Qura University
Conditions:
Apple Watch
Eligibility:
All Genders
18+ years
Brief Summary
Background: Apple Watch validity to measure the heart rate (HR) and oxygen saturation (Spo2) in healthy subjects has been investigated, but its accuracy and validity for patients with cardiac diseases...
Detailed Description
Introduction: Measuring the heart rate (HR) is important to estimate the suitable exercise training intensity and to determine the recommended exercise intensity (1). The 12-leads electrocardiogram (...
Eligibility Criteria
Inclusion
- eligible participants will be cardiac patients as those with myocardial infarction (6-weeks post-insult), coronary bypass graft surgery (CABG), cardiac patients with valve diseases, stable atrial fibrillation (AF), heart failure (HF)-I,II and III, with and resting ejection fraction (EF) greater than 50%.
Exclusion
- Cardiac patients with unstable angina, uncontrolled high blood pressure, unstable arrythmia, presence of complex ventricular arrhythmias, ST-segment depression ≥2mm from baseline during exercise testing or recovery, pacemaker patients will be all excluded from the study
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT05199844
Start Date
November 1 2022
End Date
September 30 2023
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Umm Al-Qura University Medical Center
Mecca, Saudi Arabia, 24243 7512